For Primary Prevention, Should All Moderate- to High-Risk Patients Be Considered Candidates for Acetylsalicylic Acid?

Authors

  • Jennifer Bolt (Pro) University of British Columbia
  • Peter Loewen (Con) The University of British Columbia

DOI:

https://doi.org/10.4212/cjhp.v73i1.2959

Abstract

-

Downloads

Download data is not yet available.

Downloads

Published

2020-02-20

Issue

Section

Point Counterpoint / Le pour et le contre